Add to watchlist

Zimmer Biomet Holdings, Inc. (ZBH)

Last Price$105.41.0%

Market Cap$21.6B

#ZBH Rating

#ZBH Intrinsic Value

#ZBH Share Price History

#ZBH Stock Metrics

#ZBH Stock Financials

ZBH Income Statement Metrics

#ZBH Cash Flow Statement Metrics

#ZBH Income Statement Overview

#ZBH Balance Sheet Overview

#ZBH Stock Ratios

#ZBH Earnings Surprises

#ZBH Dividends

#ZBH Dividend Yield

#ZBH Dividend Per Share

#Competing with ZBH

Overview

Ratings

Intrinsic Value

Valuation

Growth

Profitability

Health

Capital allocation

Momentum

Earnings

Dividends

Company name	Market Cap	Quality rating	Intrinsic value	1Y Return	Revenue	Free Cash Flow	Revenue growth	FCF margin	Gross margin	ROIC	Total Debt to Equity
Zimmer Biomet Holdings, Inc.ZBH ZBH	$21.6B	5.9	$181.2 72.0% undervalued	(15.3%)	$5,655.4M	$1,132.4M	(23.5%)	20.0%	64.3%	4.5%	43.0%
Abbott LaboratoriesABT ABT	$242.4B	7.0	$174.5 24.5% undervalued	19.2%	$42.0B	$6,351.0M	4.6%	15.1%	55.6%	25.3%	31.4%
Boston Scientific CorporationBSX BSX	$154.5B	6.7	$34.2 67.4% overvalued	55.5%	$16.7B	$2,438.0M	17.6%	14.6%	67.0%	8.0%	50.7%
Stryker CorporationSYK SYK	$150.5B	6.6	$305.1 22.7% overvalued	12.0%	$22.6B	$3,487.0M	10.2%	15.4%	62.8%	14.6%	28.4%
Medtronic plcMDT MDT	$120.9B	6.2	$114.6 21.5% undervalued	14.7%	$33.2B	$5,467.0M	2.7%	16.5%	52.7%	7.4%	53.6%
Edwards Lifesciences CorporationEW EW	$43.4B	6.1	$54.1 24.2% overvalued	(18.0%)	$5,872.6M	$502.2M	0.9%	8.6%	77.8%	25.8%	7.4%
DexCom, Inc.DXCM DXCM	$34.9B	7.0	$43.1 49.8% overvalued	(29.7%)	$4,033.0M	$453.9M	11.3%	11.3%	60.4%	21.7%	120.3%
Koninklijke Philips N.V.PHG PHG	$24.7B	5.3	$65.0 146.8% undervalued	34.0%	€18.0B	€274.0M	(0.8%)	1.5%	43.1%	(4.2%)	63.4%
STERIS plcSTE STE	$21.9B	6.2	$199.6 10.4% overvalued	(3.8%)	$5,398.4M	$751.4M	(0.2%)	13.9%	44.7%	8.2%	1.9%
Insulet CorporationPODD PODD	$19.4B	7.9	$134.5 50.7% overvalued	62.5%	$1,900.3M	$303.0M	12.0%	15.9%	76.4%	29.7%	6.9%
Align Technology, Inc.ALGN ALGN	$13.6B	6.0	$190.0 8.5% undervalued	(43.2%)	$3,999.0M	$622.7M	3.5%	15.6%	70.3%	14.2%	2.3%